| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $55.3M | +8001.5% |
| Cost of Revenue | $8.0M | +4674.3% |
| Gross Profit | $47.3M | +9080.4% |
| R&D Expense | $34.1M | -31.7% |
| SG&A Expense | $290.7M | +146.5% |
| Operating Income | -$277.5M | -65.8% |
| Income Tax | $0 | — |
| Net Income | -$334.3M | -65.8% |
| EPS (Basic) | -$5.29 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $297.3M | -22.1% |
| Accounts Receivable | $38.8M | +2270.0% |
| Inventory | $3.2M | +165.6% |
| Current Assets | $360.1M | -9.4% |
| Total Assets | $378.3M | -8.6% |
| Current Liabilities | $85.7M | +121.1% |
| Long-term Debt | $201.4M | +46.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$266.8M | -93.9% |
| Capital Expenditures | $135K | -91.7% |
| Investing Cash Flow | -$135K | +91.7% |
| Financing Cash Flow | $182.8M | -50.3% |
| Free Cash Flow | -$266.9M | -91.7% |
| -34.6% |
| EPS (Diluted) | -$5.29 | -34.6% |
| Total Liabilities |
| $631.9M |
| +29.9% |
| Stockholders' Equity | -$253.6M | -248.5% |